Target intelligence / Profile preview

Gs alpha subunit (Gsα)

Target
Gsα
Molecular classification
G protein subunit (heterotrimeric G protein family), Signal transduction protein, GTPase
01

Overview

The Gs alpha subunit is a component of heterotrimeric G proteins that couples hormone and neurotransmitter receptors (GPCRs) to adenylyl cyclase activation[3]. When activated (normally by GPCRs via GTP loading, or pathologically by ADP-ribosylation from toxins such as cholera toxin), Gsα stimulates adenylyl cyclase to produce cyclic AMP (cAMP), a second messenger that regulates diverse cellular processes. ADP-ribosylation of Gsα locks the protein in its active, GTP-bound form, resulting in persistent cAMP production and downstream effects[2][8]. This mechanism is exploited by bacterial toxins (notably cholera toxin) to cause pathophysiological conditions such as secretory diarrhea. Gsα is encoded by the GNAS gene in humans and is involved in numerous physiological and pathological pathways, including those related to cardiovascular, metabolic, and endocrine functions[3][5][7].

Other names
Gs alpha subunitGNAS proteinGαsStimulatory G protein alpha subunitGuanine nucleotide-binding protein Gs alpha subunit
02

Mechanism of action

ADP-ribosylation (by cholera toxin and similar toxins which irreversibly activate Gsα); GTP/GDP exchange (reversible activation via normal GPCR agonist stimulation)

03

Biological functions

Signal transductionActivation of adenylyl cyclasecAMP productionRegulation of metabolic enzyme activityModulation of cellular response to hormones and neurotransmitters
04

Disease associations

Cholera (toxins ADP-ribosylate Gsα, causing persistent adenylyl cyclase activation and diarrhea)McCune-Albright syndrome (mutation in GNAS gene)Endocrine disordersCancer (mutant GNAS/altered Gsα signaling)Cardiac dysfunction (altered β-adrenergic signaling)
05

Safety considerations

Persistent activation leads to electrolyte imbalance/dehydration via excessive cAMP-mediated salt/water secretion (as in cholera)Risk of overactivation of downstream signaling (arrhythmia, hyperglycemia, etc.)Mutation may cause various syndromic disorders
06

Interacting drugs

Cholera toxin (activator via ADP-ribosylation)

3 more in the full profile.

07

Biomarkers

cAMP levels (cellular/serum cAMP as a surrogate of Gsα pathway activation)GNAS gene mutation statusADP-ribosylated Gsα (specific to cholera and similar toxicities)

Beyond the preview

Go deeper on Gs alpha subunit (Gsα).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gs alpha subunit (Gsα).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call